CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Hou Gu Mi Xi +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03019042
NCT03019042N/ACompleted

Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Non-organic Gastrointestinal Disorders: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial

Jiangxi University of Traditional Chinese Medicine·interventional·Posted Jan 12, 2017·Updated May 11, 2020

In Brief

A clinical study evaluating Hou Gu Mi Xi and placebo for Gastrointestinal Disease. Completed, enrolled 200 participants across 1 site.

Detailed Summary

This trial aims to determine whether Hou Gu Mi Xi is an effective treatment for improving symptoms and indicators in patients with spleen qi deficiency and mild gastrointestinal disorder.

Study Details

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 12, 2017
Enrollment StartNov 15, 2016
Primary CompletionJul 10, 2018
Study CompletionJul 10, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.5 years ago

Interventions

Hou Gu Mi Xidietary

Hou Gu Mi Xi is a dietary therapy form of Shen Ling Bai Zhu San, of which removes atractylodes and platycodon grandiflorum, adds perilla leaf for adapting a dietary therapy.

placeboother

The placebo has same appearance, taste and smell as Hou Gu Mi Xi.